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Abstract
Decreased contractility in the non-ischemic border zone surrounding a MI is in part due to
degradation of cardiomyocyte sarcomeric components by intracellular matrix metalloprotei-
nase-2 (MMP-2). We recently reported that MMP-2 levels were increased in the border
zone after a MI and that treatment with doxycycline for two weeks after MI was associated
with normalization of MMP-2 levels and improvement in ex-vivo contractile protein devel-
oped force in the myocardial border zone. The purpose of the current study was to deter-
mine if there is a sustained effect of short term treatment with doxycycline (Dox) on border
zone function in a large animal model of antero-apical myocardial infarction (MI). Antero-api-
cal MI was created in 14 sheep. Seven sheep received doxycycline 0.8 mg/kg/hr IV for two
weeks. Cardiac MRI was performed two weeks before, and then two and six weeks after MI.
Two sheep died prior to MRI at six weeks from surgical/anesthesia-related causes. The
remaining 12 sheep completed the protocol. Doxycycline induced a sustained reduction in
intracellular MMP-2 by Western blot (3649±643 MI+Dox vs 9236±114 MI relative intensity;
p = 0.0009), an improvement in ex-vivo contractility (65.3±2.0 MI+Dox vs 39.7±0.8 MI mN/
mm2; p<0.0001) and an increase in ventricular wall thickness at end-systole 1.0 cm from the
infarct edge (12.4±0.6 MI+Dox vs 10.0±0.5 MI mm; p = 0.0095). Administration of doxycy-
cline for a limited two week period is associated with a sustained improvement in ex-vivo
contractility and an increase in wall thickness at end-systole in the border zone six weeks
after MI. These findings were associated with a reduction in intracellular MMP-2 activity.
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Introduction
Segmental shortening in the border zone region adjacent to a myocardial infarction (MI) is
depressed, even when the border zone has a normal blood supply [1]. While the decrease in
border zone function was previously thought to be secondary to mechanical load [2], compu-
tational (finite element) modeling studies show that border zone contractility must be
decreased by approximately 50% [3]. This finding has now been confirmed by studies in
demembranated strips of myocardium obtained from the border zone after antero-apical MI
in sheep [4].
The border zone in the current study is not the millimeter wide border zone comprised of
interdigitating ischemic and normal myocardium described in the 1980s by Janse and others
[5]. Rather, the border zone in the current study is a region with decreased contraction that is
adjacent to the MI zone. It is larger than previously thought, extending as far as 3 cm from the
edge of the infarct [6] and the region of dysfunction expands in size over time [1]. Progression
of border zone size and dysfunction may contribute to post-MI ventricular remodeling and
subsequent heart failure [1].
Matrix metalloproteinases (MMP) were initially defined by their involvement in remodel-
ing of the extracellular matrix. However, a specific MMP, matrix metalloproteinase-2 (MMP-
2) also acts within the cardiomyocyte. Two discrete isoforms of intracellular MMP-2 have
been identified. The first consists of the full length MMP-2 (FL-MMP-2) isoform previously
considered to only have a role in cardiac extracellular matrix remodeling. Several studies have
shown that a significant fraction of synthesized FL-MMP-2 is retained in an enzymatically
latent form within cardiomyocytes in direct association with sarcomeric components. Oxida-
tive stress induced by ischemia/reperfusion injury can activate sarcomere-associated FL-
MMP-2, an event that results in the cleavage of troponin I (TnI) [7], myosin light chain 1
(MLC-1) [8] and titin [9] with an associated reduction in contractile force. In addition, a sec-
ond recently characterized isoform of MMP-2 is generated by oxidative stress-mediated activa-
tion of an alternate promoter located in the first intron of the MMP-2 gene. This event results
in the synthesis of a N-terminal truncated isoform of MMP-2 (NTT-MMP-2) that remains
intracellular, is enzymatically active, and is physically associated with mitochondria [10]. Car-
diac-specific transgenic expression of the NTT-MMP-2 isoform results in inflammation, cardi-
omyocyte necrosis and impaired contractility due to defects in calcium handling [11, 12].
Studies of MMP inhibitors on LV function and remodeling after MI in animals and humans
have had mixed results. Doxycycline increases wall thickness in the MI border zone and
decreases passive compliance after coronary artery occlusion MI in the rat [13]. Relatively
selective inhibition of MMPs 2, 3 and 13 (PD166793) decreases infarct expansion after coro-
nary artery occlusion MI in the pig [14]. Short-term doxycycline therapy reduced LV remodel-
ing in patients with acute ST-elevation myocardial infarction (TIPTOP trial) [15]. In contrast,
non-selective inhibition of MMPs 2, 3, 8, 9, 13 and 14 (PG116800) had no beneficial effect on
post-infarction LV remodeling in humans (PREMIER trial) [16]. To date, no studies have
looked at the effect of MMP inhibition on post-myocardial ventricular function in the nor-
mally perfused LV border zone.
Doxycycline (Dox) non-selectively inhibits MMPs by chelating the structural Zn2+ required
for catalytic activity [17]. In addition, doxycycline can inhibit MMP transcription. Doxycycline
also has free radical scavenger, anti-apoptotic [17] and immune modulatory effects [18].
We recently reported that treatment with doxycycline for two weeks after MI was associated
with normalization of MMP-2 levels and improvement in ex-vivo contractile protein devel-
oped force in the myocardial border zone two weeks after infarction [4]. The purpose of the
Doxycycline improves border zone contractility
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current study was therefore to determine if there is a sustained effect of short term treatment
with doxycycline on border zone function in a large animal model of antero-apical MI.
Methods
Experimental animals
Sheep were acquired from a local ranch (Pozzi Ranch, Sebastapol, CA). A Q-fever titer was
acquired prior to animal purchase and then twice during a three week quarantine at the animal
facility. Only sheep with three negative titers were used.
Sheep were housed singly for 48 hours following each surgical procedure. They were then
housed in pairs in runs (48 sq. feet) that had the floor covered with pine shavings and that
were enriched with a salt block and a mirror. Housing was cleaned daily. Sheep were fed a pre-
pared ruminant diet (Envigo, Huntington, Cambridgeshire, UK) and fresh alfalfa hay twice
daily.
Sheep were checked daily and posture, temperature, respiratory rate, urine and fecal output
and incision status were recorded. Sheep were weighed on arrival and then every two weeks.
Anesthesia and pain control. Anesthesia for MI, MRI and sacrifice/ tissue harvest proce-
dures in chronic animals was similar. Briefly, anesthesia was induced with ketamine (20 mg/
kg intravenous) and maintained with isoflurane (2.2% inhaled). End-tidal CO2 was kept
between 25 and 45 mmHg and an infusion of neosynephrine was titrated to keep peak LV
pressure at 90±5 mm Hg during cardiac MRI and Swan Ganz catheter measurements.
Post-operative pain associated with the MI procedure was controlled with a transdermal
fentanyl patch (1–2 ug/kg/hr continuous) started 24 hours prior to surgery and continued for
3 days after surgery. In addition, at the conclusion of MI and MRI procedures, the incision
was infiltrated with a long acting local anesthetic (Bupivacaine 0.5% x 10 ml) and a non-steroi-
dal anti-inflammatory (Banamine, 1.1 mg/kg) was given intra-muscularly once and as needed
for post-operative pain.
Non-operated controls. Three adult unoperated sheep were sacrificed to obtain ‘non-
operated’ control myocardial tissue. Those animals were given pentobarbital (150 mg/ kg IV)
prior to rapid cardiectomy and tissue harvest as described below.
Experimental protocol
Sheep were treated under a protocol approved by the San Francisco VA Institutional Animal
Care and Use Committee (IACUC), in compliance with the “Guide for the Care and Use of
Laboratory Animals” prepared by the Institute of Laboratory Animal Resources, National
Research Council.
Briefly, antero-apical MI was created in 14 sheep. Of those, seven sheep received doxycy-
cline 0.8 mg/kg/hr IV for two weeks. Cardiac MRI was performed two weeks before, and then
two and six weeks after MI (Fig 1).
Myocardial infarction. Fourteen adult sheep underwent antero-apical MI, as previously
described [19]. The left anterior descending (LAD) and LAD diagonal branches were ligated at
a point 40% of the distance from the LV apex to the base of the heart.
Doxycycline administration. Sheep designated for doxycycline treatment had an indwell-
ing catheter (Groshong, Bard Medical, Covington, GA) implanted at the time of MI and
advanced to the superior vena cava-right atrial junction. The catheter was tunneled to the ani-
mal’s back and connected to a continuous flow pump (Ambit, Sandy, UT). Sheep received
doxycycline (0.8 mg/ kg/ hr or 19.2 mg/ kg/ day) IV continuously for 2 weeks. Doxycycline
was started immediately prior to MI. The daily dose of doxycycline was identical to our previ-
ous study [4].
Doxycycline improves border zone contractility
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Cardiac magnetic resonance imaging (MRI). Cardiac MRI was performed two weeks
before, and then two and six weeks after MI, as described [20]. Briefly, six radial cine long axis
images 30o apart were obtained (Fig 2). ferumoxytol (0.125 ml/ kg IV over 1 hour; AMAG
Pharmaceuticals, Waltham, MA) was given prior to MRI [21].
Swan Ganz catheter measurements. Following cardiac MRI, a Swan Ganz catheter was
inserted and advanced to the pulmonary artery using fluoroscopic guidance. Cardiac output
and pulmonary artery wedge pressure (PCWP) measurements were obtained.
Tissue harvest. Cardiac arrest was achieved by retrograde aortic infusion of 4˚C hyperka-
lemic solution (Plegisol, Hospira Inc, Lake Forest, IL plus 10 mL/L 8.4% NaHCO3, pH 7.8).
Tissue samples were taken from the MI, border zone and remote anterior wall for histology,
muscle strip mechanics and biochemistry. The border zone tissue sample was obtained 0–1 cm
from the infarct edge.
MRI image analysis
Fig 2 shows representative three-chamber long axis MRI images obtained at end-systole (ES)
from control (B) and doxycycline (C) sheep 6 weeks after MI. LV endocardial and epicardial
borders were manually contoured (MeVisLab, MeVis Medical Solutions, Bremen, Germany)
and 3D triangular element surfaces created. Cavity and wall volumes of the LV at end diastole
(ED) and ES were calculated (MeVisLab) [20]. LV volume measurements were indexed to
body surface area [22] to the 1.5 power [23].
Points on the MI border were identified in each of the six long axis cine MRI images as the
inflection between the region with contractile function and the constant thickness MI zone
(Fig 2B and 2C). Epicardial and endocardial 3D spline contours were created from the MI
border points and from points 3 cm toward the LV base on the LV epicardial and endocardial
surfaces. A finite element mesh consisting of 1,728 hexahedral elements was projected to the
epicardial and endocardial surfaces and designated elements were attached to the MI and bor-
der zone spline contours (TrueGrid, XYZ Corp, Livermore, Ca) (Fig 3A and 3B). Wall thick-
ness was determined by measuring the mesh thickness at the MI border and at centimeter
increments along the LV border zone. Each measurement was repeated at each of the 24 ele-
ments around the circumference.
Ex-vivomyofilament contractility
Thin slices of epicardial myocardium from border zone and remote myocardium were pinned
onto a silicone substrate and chemically demembranated using a solution containing 1%
Fig 1. Experimental timeline.
https://doi.org/10.1371/journal.pone.0192720.g001
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Triton X-100 (Sigma-Aldrich, St Louis, MO) for 24 h at 4˚C [4]. Demembranated slices were
stored at -20˚C (for up to several weeks before study) in a solution that was a 1:1 mixture of
glycerol and relaxing solution containing (in mM) 20 EGTA, 7.05 MgCl2, 6.31 Na2ATP, 10
creatine phosphate, and 80 N,N-bis(2-hydroxyethyl)2-aminoethane sulfonic acid, with pH
adjusted to 7.1 with KOH and ionic strength adjusted to 200 mM with KCl. Relaxing solution
also contained 1% (vol/vol) Protease Inhibitor Cocktail P-8340 and 10 IU/ml creatine kinase
(Sigma).
Developed force of demembranated myocardial samples was measured as described [4].
Visually discrete cardiac muscle bundles (diameter 100 μm—150 μm) running in the plane of
the slice were dissected free. Muscle bundles were cut to a length of 1.5 mm and attached with
aluminum T-clips to a force transducer (Permeabilized Fiber Test System, model 1400A,
Aurora Scientific, Aurora, ON, Canada) and bathed in relaxing solution. Muscle sarcomeres
Fig 2. Representative MRI imaging data. Panel A is from control sheep two weeks prior to MI, panel B is from control animal six weeks after MI and
panel C is from doxycycline animal six weeks after MI. All images are of the three-chamber long axis obtained at end systole. Epicardial and
endocardial contour lines are in yellow. The red line is the manually determined MI perimeter. The red arrow marks the edge of the MI and white
arrows mark the points of 1, 2, and 3 cm from the infarct edge.
https://doi.org/10.1371/journal.pone.0192720.g002
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were observed using a 40X objective, and sarcomere lengths were assessed using a video-based
system (model 900B, Aurora Scientific). Muscle length was adjusted to set the muscle
Fig 3. LV wall thickness at end-systole six weeks after MI. Panels A and B are color maps of LV wall thickness at end-systole six weeks after MI
from representative MI control (A) and MI + Dox (B) animals. Maps are oriented with the anterior wall toward the viewer and colors range from
black (< 2 mm) to brown (>14 mm). Panel C shows the effect of Doxycycline on wall thickness at end-systole in 1 cm increments from the MI
edge. Note that data is from the entire LV. p<0.05.
https://doi.org/10.1371/journal.pone.0192720.g003
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sarcomere length to 2.1 μm. Demembranated preparations were briefly transitioned to preacti-
vating solution in which Ca2+ buffering was reduced by replacing 19.5 mM EGTA with hexam-
ethylenediamine-N,N,NV,NV-tetraacetate (Honeywell Fluka, Seelze, Germany). Muscles were
then transitioned to an activating solution containing 20 mM Ca2+-EGTA. Maximum devel-
oped force was assessed from the contraction force in activating solution minus the passive
force measured in relaxing solution, normalized to the muscle cross-sectional area (mN/mm2).
Data were pooled from two to four muscle preparations obtained per region per heart.
MMP-2 immunohistochemistry
Immunohistochemistry of FL-MMP-2 and NTT-MMP-2 isoforms was performed as described
[24]. In brief, to detect the FL-MMP-2 isoform we used an antibody to the N-terminal prodo-
main of MMP-2 (AB54401, Abcam, Cambridge, MA). For immunostaining of the NTT-MMP-
2 isoform, the sections were incubated overnight at 4˚ C with an affinity-purified goat IgG (5μg
IgG/ml PBS/BSA) targeting the S1’ substrate binding sequence (P347YTYTKNFRLSQDD361)
located adjacent to the catalytic site [24].
MMP-2 western blot
Western blotting was performed on protein isolated from fresh-frozen border zone tissue
using antibodies to FL-MMP-2 and NTT-MMP-2 that were previously described [24]. Relative
abundance of the MMP-2 protein was normalized to GAPDH.
MMP-2 qPCR
Paraffin-embedded sections (15 μm) of anterior border zone tissue were deparaffinized and
RNA was extracted using an RNeasy FFPE kit (Qiagen, Hilden, Germany). RNA was quanti-
fied and normalized to synthesize cDNA using the Maxima First Strand cDNA Synthesis kit
for RT-qPCR, with dsDNase (Thermo Fisher Scientific, Waltham, MA. The relative expression
of FL-MMP-2 and NTT-MMP-2 transcripts between border zone tissue from MI, MI + Dox
and non-operated controls were determined using a LightCycler 480 SYBR Green I Master kit
(Roche Applied Science, Penzberg, Germany). Samples were plated in triplicate in 384 well
PCR plates (Thermo Fisher Scientific). Primers were designed to assay for the sheep FL-MMP-
2 transcript (F: 5’–AGATGCAGAAGTTCTTGGGT– 3’, R: 5’–CTCTGGTCCAGTTCACC
TGT– 3’) and the NTT-MMP-2 transcript (F: 5’–GTGTGCTTGCAAGAAGTGGG– 3’, R:
5’–GTCCAGTTCACCTGTCTGGG– 3’). Amplification reactions were performed with 40
cycles (95˚C for 15 seconds; 56˚C for 30 seconds; and 72˚C for 1 minute) and normalized to
the ribosomal protein L19 (RPL19) transcript (F: 5’–AGCCTGTGACTGTCCATTCC– 3’, R:
5’–ACGTTACCTTCTCGGGCATT– 3’). 25 Comparative results are expressed using the 2 ΔΔ
Ct method [25].
Fluorescent imaging of reactive oxygen species (ROS)
Samples from the anterior border zone and remote myocardium were snap-frozen in liquid
nitrogen cooled isopentane and stored at -80˚C prior to analysis. Intracellular superoxide was
measured with the fluorescent probe dihydroethidium (DHE; Molecular Probe, Eugene, OR)
[26]. Hydroxide ion was measured using dichlorofluorescein (DCF; Molecular Probe) [26] in
8.0μm thick frozen sections as described. Images of ROS stained sections were analyzed using
ImageJ (NIH, Bethesda, MD). Specifically, the respective ROS stain was the percent area that
was positive with a green filter.
Doxycycline improves border zone contractility
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Histology
Samples from the border zone and remote myocardium were fixed in phosphate-buffered 4%
paraformaldehyde (Thermo Fisher Scientific) at 4˚C overnight, followed by storage in 70%
ethanol at 4˚C. Paraffin-embedded sections (5 μm) were stained with hematoxylin and eosin.
Statistical analysis
All values are expressed as mean ± standard error of the mean. The significance level was set at
p<0.05.
A multivariate mixed effect analysis (Proc Mixed, SAS version 9.2, SAS Institute Inc., Cary,
NC) was performed. Individual sheep were included as a random effect [27]. The Bonferroni
method was used to correct for multiple comparisons.
Results
Average initial animal weights (MI: 62.0±1.9 and MI+Dox: 56.2±2.9 Kg) and weight gain (MI:
4.9 and MI+Dox: 7.3 Kg) in the two groups were similar (Table 1).
Two animals died immediately prior to MRI study six weeks after MI from anesthesia
related causes. The remaining 12 animals completed the protocol.
Effect on regional LV function
The effect of Doxycycline on regional LV wall thickness at end-systole six weeks after MI is
seen in Fig 3. Color maps of LV wall thickness from representative MI control (A) and MI +
Dox (B) animals show a generalized increase in wall thickness at ES across the border zone
and remote LV myocardium. Panel C shows the effect of Doxycycline has a statistically signifi-
cant effect on wall thickness at end-systole beginning 2 cm above the MI border and extending
into the remote myocardium. Doxycycline had no statistically significant effect on wall thick-
ness at end-diastole (Data not shown).
Table 1. Cardiac MRI measurements.
2 weeks prior to MI
(n = 14)
2 weeks after MI
(n = 7)
2 weeks after MI +Dox
(n = 7)
6 weeks after MI
(n = 7)
6 weeks after MI
+Dox
(n = 5)
Weight [Kg] 59.1±2.1 61.8±2.4 57.9±2.8 66.9±2.6 63.5±4.4
Long axis at ED [mm] 85.5±1.9 91.9±7.6 91.1±9.7 91.3±1.9 97.2±4.0
Short axis at ED [mm] 38.3±1.5 42.2±7.1 44.2±2.6 45.4±4.6 49.9±2.7
Sphericity at ED 0.45±0.02 0.470±0.112 0.490±0.070 0.497 ± 0.048 0.517±0.034
Apical Conicity at ES 0.700±0.04 0.510±0.071 0.510 ± 0.035 0.546±0.024 0.555±0.037
MI Perimeter at ED [mm] NA 7.8±0.7 7.9±0.69 7.4±0.4 7.9±0.7
MI Area at ES [cm2] NA NA NA 4.96±0.38 5.31±0.56
LV Volume Index at ED [ml/ m2] 108.3±5.2 136.7±6.2 142.1±11.0 145.0±10.5 151.1±17.0
LV Volume Index at ES [ml/ m2] 63.2±3.4 91.4±6.3 103.1±7.8 103.3±7.6 108.6±13.3
LV Wall Volume at ED [ml] 127.9±5.5 117.3±7.5 130.0±8.7 146.0±5.4 143.4±5.8
Ejection Fraction [%] 41.4±2.3 33.5±2.6 27.2±3.4 28.2±4.3 28.5±4.2
Values are expressed as mean ± standard error of the mean. LV volumes are indexed to body surface area to the 1.5 power. 23ED-end-diastole; ES-end-systole.
 = p < 0.05 with respect to 2 weeks prior to MI.
https://doi.org/10.1371/journal.pone.0192720.t001
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Effect on global LV function and shape
Table 1 shows measurements obtained from cardiac MRI. Briefly, the long and short axes, and
LV volume at ED trended larger with doxycycline, but the changes were not significant. Both
LV sphericity and conicity were not different after doxycycline treatment.
MI perimeter and MI area trended higher with Doxycycline. As a consequence, and in spite
of the increase in wall thickness at ES in the border zone and remote myocardium, LV volume
at ES was not significantly different.
Table 2 shows Swan Ganz catheter measurements, including stroke volume and PCWP.
Stroke volume trended higher and PCWP trended lower with doxycycline treatment; however,
the changes were not significant. Multivariate analysis of a composite created by adding stroke
volume and PCWP values normalized with pre-MI mean and standard deviation trended
toward a modest doxycycline effect (p = 0.075).
Ex-vivomyofilament contractility
Fig 4 shows the effect of doxycycline on maximum myofilament developed force assessed
using demembranated cardiac muscle preparations from the infarct border zone six weeks
after MI. Maximum developed force in the infarct border zone was 52.7% (p<0.001) of remote
myocardium and 59.9% (p<0.001) in myocardium from non-operated sheep. Developed force
in border zone myocardium of doxycycline treated sheep was 65% (p<0.0001) higher than the
border zone after MI and not different from remote myocardium or border zone of non-oper-
ated controls. Passive force was unchanged by MI or doxycycline (not shown).
Intracellular MMP-2
Fig 5A shows the effects of doxycycline on immunohistochemical staining for the FL-MMP-2
and NTT-MMP-2 isoforms in the infarct border zone 6 weeks after MI. Cardiomyocyte stain-
ing for the FL-MMP-2 isoform in the controls shows strong immuno-histochemical reaction
product decorating sarcomeres, while NTT-MMP-2 staining was present in particulate, linear
arrays characteristic of a mitochondrial localization, as previously reported [11]. Doxycycline
treatment significantly reduced expression of both MMP-2 isoforms as determined by
immunohistochemistry.
Fig 5B shows the effect of doxycycline on MMP-2 protein level by Western blot using a
MMP-2 antibody that recognizes both the FL-MMP-2 and NTT-MMP-2 isoforms. Given the
limits on molecular mass resolution of SDS-PAGE gels, it is not possible to clearly distinguish
between the 68 kDa FL-MMP-2 and the 65 kDa NTT-MMP-2 protein isoforms and the results
are expressed in terms of total intracellular MMP-2 protein content. Compared to the non-
operated controls, total MMP-2 protein was not changed in the infarct border zone, but was
Table 2. Swan Ganz catheter measurements.
2 weeks prior to MI
(n = 14)
2 weeks after MI
(n = 7)
2 weeks after MI +Dox
(n = 7)
6 weeks after MI
(n = 7)
6 weeks after MI +Dox
(n = 5)
Heart Rate [bpm] 83.6±6.4 89.6±10.0 74.3±3.4 81.6±7.3 81.4±7.4
Cardiac Output [L/min] 5.6±0.4 5.3±0.6 4.4±0.7 4.8±0.4 5.3±0.5
Stroke Volume [ml] 68.4±5.0 60.4±5.7 59.2±9.0 60.9±5.0 69.0±11.2
PCWP [mm Hg] 5.8±0.6 13.3±2.3 10.9±1.5 11.6±1.7 7.8±1.9
Values are expressed as mean ± standard deviation. PCWP-pulmonary capillary wedge pressure.
p < 0.05 with respect to 2 weeks prior to MI.
https://doi.org/10.1371/journal.pone.0192720.t002
Doxycycline improves border zone contractility
PLOS ONE | https://doi.org/10.1371/journal.pone.0192720 February 12, 2018 9 / 17
decreased by 60.5% (p = 0.0009) in the infarct border zone in the doxycycline treated group as
compared to MI control.
MMP-2 qPCR
Fig 5D and 5E show an increase in expression of the FL-MMP-2 and NTT-MMP-2 transcripts
in the MI border zone after MI (combined effect: p = 0.0184) and a trend toward reduction
with doxycycline (combined effect: p = 0.0646). Both were relative to the normalizing L19
ribosomal protein gene.
ROS
Fig 6 shows the effect of doxycycline on superoxide and hydroxide production in the border
zone six weeks after MI. There was minimal staining for superoxide in the non-op control
myocardium. After MI, there was significant superoxide activity co-localized to the myocyte
nucleus and hydroxide activity localized in a punctate pattern consistent with mitochondrial
localization (Panels A and B; MI BZ Merge). Treatment with doxycycline was associated with
a significant reduction in superoxide and hydroxide in both the remote and border zone myo-
cardium (Panels C and D).
Discussion
The principal finding of the study is that administration of doxycycline for a limited two week
period following acute MI is associated with a sustained improvement in ex-vivo contractility
and an increase in wall thickness at end-systole in the border zone six weeks after MI. The
effect is associated with a reduction in intracellular expression of both the FL-MMP-2 and
NTT-MMP-2 isoforms.
Fig 4. Effect of doxycycline on maximum myofilament developed force six weeks after MI. The statistical
comparison is with MI border zone control.  = p< 0.0001 with respect to MI border zone.
https://doi.org/10.1371/journal.pone.0192720.g004
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Fig 5. Effect of doxycycline on MMP-2 in the infarct border zone six weeks after MI. Panel A shows the effect on MMP-2 using
immunohistochemistry and panels B and C show western blot results. Panel A subpanels C and D were done using Nomarski optics. FL-MMP-2
staining is sarcomeric while the NTT-MMP-2 staining shows punctate, linear arrays of antibody staining between sarcomeres (black arrows). p<
0.05. The effect of doxycycline on full length (D) and truncated (E) MMP-2 RNA. p<0.05 for combined FL-MMP-2 and NTT-MMP-2 RNA
effect. n = 4 for MI control and MI + Dox groups, n = 2 for non-operated control.
https://doi.org/10.1371/journal.pone.0192720.g005
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Proposed mechanism
Our proposed mechanism is that increased intracellular ROS activates existing intracellular
FL-MMP-2 [28] and induces transcription of NTT-MMP-2 [10]. Activated FL-MMP-2 causes
Fig 6. Effect of doxycycline on reactive oxygen species in the infarct border zone six weeks after MI. Panel A shows the effect on superoxide and
panel B on hydroxide. Superoxide was measured dihydroethidium (DHE) and hydroxide was measured with dichlorfluorescein (DCF).
DAPI = 4’,6-diamidino-2-phenylindole. Panels C and D show the % area of superoxide (DHE) and hydrogen peroxide (DCF) staining respectively.
n = 3 for MI control and MI + Dox groups, n = 2 for non-operated control.
https://doi.org/10.1371/journal.pone.0192720.g006
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lysis of sarcomeric proteins leading to decreased myofilament force development and reduced
LV function. Oxidative stress not only actives FL-MMP-2 but also stimulates transcription
through an AP-1 enhancer element located in the promoter of the MMP-2 gene [29, 30]. Simi-
larly, oxidative stress induces NTT-MMP-2 transcription through a NFκB enhancer element
located near to the proximal promoter in the first intron of the MMP-2 gene. NTT-MMP-2
subsequently impairs mitochondrial bioenergetics and induces a primary innate immune
response associated with cardiomyocyte death and decreased contractile force due to defects
in calcium handling. The source of intracellular ROS in the infarct border zone is likely a result
of NTT-MMP-2 induced mitochondrial dysfunction or alternatively mechano-transduction of
increased mechanical stress via NADPH Oxidase (NOX-2) [31].
Doxycycline effect
During the period of drug administration, doxycycline directly inhibits FL-MMP-2 and NTT-
MMP-2 activity via chelation of structural Zn2+ required for catalytic activity [17]. The
decrease in NTT MMP-2 activity is associated with a reduction in mitochondrial damage
which in turn prevents the amplification of intracellular ROS production. Doxycycline may
also act as a direct free radical scavenger [17]. Last, the doxycycline mediated reduction in
intracellular ROS generation prevents transcriptional amplification of both MMP-2 isoforms.
These proposed actions are consistent with the finding that MMP-2 mRNA and protein levels
and intracellular ROS were significantly decreased in doxycycline-treated animals.
The sustained improvement in border zone contractility after a limited two week period of
doxycycline administration requires comment. Given that the half-life of doxycycline is
approximately 15–18 hours, it is very unlikely that the sustained beneficial effect of a two week
course of doxycycline treatment is a consequence of persistence of doxycycline in the infarct
border zone at four weeks following discontinuation of administration [32].
A corollary is that the stimulus for intracellular ROS production by either mitochondrial
dysfunction or mechano-transduction of high mechanical stress must be short lived or else
ROS and MMP-2 activity would recur in the absence of doxycycline. Cytokines, such as TNF-
α [33], and monocytes are known to rapidly increase in remote myocardium after MI in the
mouse. Monocyte numbers peak on day 10 following MI and then decline precipitously [34].
Infiltration of inflammatory cells in the border zone has not been measured but is assumed to
be similar.
Along those lines, it is interesting that the doxycycline effect is sustained given that mechan-
ical stress and strain in the border zone remain abnormal after the acute post- MI period [1,
35] and NOX-2 should therefore continue to generate the ROS and downstream MMP-2
effects described above. Possibly, NOX-2-based mechano-transduction ceases late after MI
due to accommodation to mechanical stress.
Contractile protein dysfunction in the infarct border zone
Shimkunas and colleagues recently showed that maximal developed force generated by
demembranated myocardium dissected from the anterior border zone of sheep two weeks
after MI was decreased by 34% [4]. First, comparison with the results of this study where maxi-
mum myofilament developed force from the border zone six weeks after MI was decreased by
46% suggests that contractile protein dysfunction is a progressive time dependent phenomena.
Further, Shimkunas found that dysfunction of myofilaments from the infarct border zone
involved impaired cross bridge formation and decreased myosin light chain-1 phosphoryla-
tion, possibly due to the action of FL-MMP-2 [4]. Although not measured in this study, the
same mechanism may be operative six weeks after MI.
Doxycycline improves border zone contractility
PLOS ONE | https://doi.org/10.1371/journal.pone.0192720 February 12, 2018 13 / 17
Border zone dysfunction in vivo
In addition to contractile protein dysfunction per se [4], defects in calcium handling machin-
ery [36], and energy available to support contraction [37] are present in vivo in the region adja-
cent to a myocardial infarction. Lovett and colleagues recently studied cardiomyocyte
contractility in intact cells taken from NTT-MMP-2 transgenic mice [11]. Lovett found that
myofilament force generation was unchanged but intact cell force generation and the ampli-
tude of Ca2+ transients were decreased by 50%. These findings are consistent with predomi-
nant localization of the NTT-MMP-2 in sub-sarcolemmal mitochondria [11] While we did not
measure Ca2+ transients or high energy phosphate levels in this study, the increase in
NTT-MMP-2 in the border zone in the current study suggests that NTT-MMP-2 upregulation
contributes to border zone contractile dysfunction in vivo.
Effect on global LV anatomy and function
These experiments were done in part to determine the effect of improved border zone function
after MI on global LV pump function. To that end, we previously simulated the effect of an
improvement in border zone contractility on end-systolic elastance and Starling’s law using
finite element models based on MRI images of five sheep after antero-apical MI [38]. With a
50% increase in border zone contractility, those simulations predicted a decrease in LV volume
at end-systole of 5.8 ml at 90 mm Hg afterload and an increase in stroke volume of 4.6 ml at
LV end-diastolic pressure of 10 mm Hg [38]. In retrospect, those predictions were partially
accurate as stroke volume increased by 6.6 ml with doxycycline (Table 2). However, the
increase in stroke volume was associated with a trend toward increased LV volume. The rea-
sons for this are unclear but infarct wound healing and subsequent infarct expansion are likely
affected by doxycycline.
Limitations
There are several limitations in the present study. First, specific downstream targets of
FL-MMP2 including MLC-1, TnI, Titin and targets of NTT-MMP-2 including Ca2+ handling
and mitochondrial function were not measured. In addition, implantation of an MRI compati-
ble marker at the infarct edge at the time of MI would have allowed more accurate measure-
ment of the effect of doxycycline on infarct expansion.
Conclusion and future directions
The principal finding of the study is that administration of doxycycline for two weeks is associ-
ated with a sustained improvement in ex-vivo contractility and increase in wall thickness at
end-systole in the border zone six weeks after MI. The effect is likely mediated by a reduction
in intracellular MMP-2 activity.
Future studies using more selective MMP inhibition and ROS scavenging agents are war-
ranted. Direct border zone therapy could also be part of multimodality treatment strategies
that include therapies designed to limit infarct expansion including passive constraint of the
infarct.
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